Literature DB >> 27084565

Testosterone therapy for transgender men.

Michael S Irwig1.   

Abstract

Testosterone therapy is a cornerstone of medical treatment for transgender men who choose to undergo it. The goal of testosterone therapy is usually to achieve serum testosterone concentrations in the male reference range. Testosterone has several desired effects as well as undesired and unknown effects. The desired effects include increased facial and body hair, increased lean mass and strength, decreased fat mass, deepening of the voice, increased sexual desire, cessation of menstruation, clitoral enlargement, and reductions in gender dysphoria, perceived stress, anxiety, and depression. Achievement of these goals comes with potential undesired effects and risks including acne, alopecia, reduced HDL cholesterol, increased triglycerides, and a possible increase in systolic blood pressure. An additional benefit of testosterone therapy (with or without mastectomy) is a reduced risk of breast cancer. Most of the effects of testosterone start to develop within several months of starting therapy, although facial hair and alopecia continue to develop after 1 year. A major limitation in the study of testosterone therapy for transgender men is a paucity of high-quality data due to a shortage of randomised controlled trials (partly because of ethical issues), few prospective and long-term studies, the use of suboptimum control groups, loss to follow-up, and difficulties in recruitment of representative samples of transgender populations.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27084565     DOI: 10.1016/S2213-8587(16)00036-X

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN: 2213-8587            Impact factor:   32.069


  31 in total

Review 1.  Dermatologic care for lesbian, gay, bisexual, and transgender persons: Epidemiology, screening, and disease prevention.

Authors:  Howa Yeung; Kevin M Luk; Suephy C Chen; Brian A Ginsberg; Kenneth A Katz
Journal:  J Am Acad Dermatol       Date:  2019-03       Impact factor: 11.527

Review 2.  Endocrine treatment of aging transgender people.

Authors:  Louis J Gooren; Guy T'Sjoen
Journal:  Rev Endocr Metab Disord       Date:  2018-09       Impact factor: 6.514

Review 3.  Contraception across transgender.

Authors:  Ilaria Mancini; Stefania Alvisi; Giulia Gava; Renato Seracchioli; Maria Cristina Meriggiola
Journal:  Int J Impot Res       Date:  2021-02-08       Impact factor: 2.896

Review 4.  Effects of hormones and hormone therapy on breast tissue in transgender patients: a concise review.

Authors:  Harsh Patel; Victor Arruarana; Lucille Yao; Xiaojiang Cui; Edward Ray
Journal:  Endocrine       Date:  2020-02-17       Impact factor: 3.633

Review 5.  The Perioperative Care of the Transgender Patient.

Authors:  Luis Etienne Tollinche; Chasity Burrows Walters; Asa Radix; Michael Long; Larissa Galante; Zil Garner Goldstein; Yvonne Kapinos; Cindy Yeoh
Journal:  Anesth Analg       Date:  2018-08       Impact factor: 5.108

Review 6.  Acne and the Lesbian, Gay, Bisexual, or Transgender Teenager.

Authors:  Laura Ragmanauskaite; Benjamin Kahn; BaoChau Ly; Howa Yeung
Journal:  Dermatol Clin       Date:  2019-11-26       Impact factor: 3.478

Review 7.  Routine Screening for Transgender and Gender Diverse Adults Taking Gender-Affirming Hormone Therapy: a Narrative Review.

Authors:  Sean J Iwamoto; Frances Grimstad; Michael S Irwig; Micol S Rothman
Journal:  J Gen Intern Med       Date:  2021-02-05       Impact factor: 5.128

8.  Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-Term Follow-Up Study on Prevalence, Determinants, and Exposure Years.

Authors:  Milou Cecilia Madsen; Dennis van Dijk; Chantal Maria Wiepjes; Elfi Barbara Conemans; Abel Thijs; Martin den Heijer
Journal:  J Clin Endocrinol Metab       Date:  2021-05-13       Impact factor: 5.958

9.  The Relationship Between Tobacco Use and Legal Document Gender-Marker Change, Hormone Use, and Gender-Affirming Surgery in a United States Sample of Trans-Feminine and Trans-Masculine Individuals: Implications for Cardiovascular Health.

Authors:  Jeremy D Kidd; Curtis Dolezal; Walter O Bockting
Journal:  LGBT Health       Date:  2018-10       Impact factor: 4.151

10.  Incidence and Factors Associated With Acne Among Transgender Patients Receiving Masculinizing Hormone Therapy.

Authors:  Nick Thoreson; Jason A Park; Chris Grasso; Jennifer Potter; Dana S King; Linda G Marc; Changyu Shen; J Klint Peebles; Erica D Dommasch
Journal:  JAMA Dermatol       Date:  2021-03-01       Impact factor: 10.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.